leadf
logo-loader
viewNaturally Splendid Enterprises Ltd.

Naturally Splendid provides data after receiving Health Canada Information request

Naturally Splendid (CVE: NSP- OTCPINK: NSPDF) CEO Craig Goodwin joined Steve Darling from Proactive to share news the company has responded to Health Canada's Information Request Notice. The IRN was designed to determine the final dosage of Cavaltinib intended for use as a COVID treatment and to define the final criteria for the selection of patients making up the test and control groups for the trial.

Goodwin talks about this step in the process and of they have been given any timelines from Health Canada.

Quick facts: Naturally Splendid Enterprises Ltd.

Price: 0.06 CAD

TSX-V:NSP
Market: TSX-V
Market Cap: $12.11 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Naturally Splendid Enterprises Ltd. named herein, including the promotion by the Company of Naturally Splendid Enterprises Ltd. in any Content...

FOR OUR FULL DISCLAIMER CLICK HERE

Naturally Splendid secures North American rights to distribute plant-based...

Naturally Splendid (CVE: NSP-OTCQB: NSPDF) CEO Craig Goodwin joined Steve Darling from Proactive Vancouver with news the company has obtained the exclusive rights for North America to distribute a plant-based food line out of Australia. That line will go under the name Natera Plant-Based Foods...

3 weeks, 1 day ago

2 min read